SEN. HATCH, REP. DINGELL ASK FDA FOR SIX-MONTH GENERIC DRUG REVIEW "MANAGEMENT PLAN"; FDA SHOULD BE ABLE TO REVIEW 20-25 ANDAs PER MONTH, CONSULTANT SAYS